Press release
Lung Cancer Vaccine Market Lung Cancer Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990Report Table of Contents
What are Cancer Vaccines?
Mechanism of Cancer Vaccines
2.1 Idiotype Cancer Vaccine Mechanism
2.2 Cellular Cancer Vaccines Mechanism
2.3 Ganglioside Antigens based Cancer Vaccines Mechanism
2.4 Peptide Cancer Vaccine Mechanism
2.5 Tumor Host Interaction Cancer Vaccine Mechanism
Overview of Lung Cancer Proliferation
3.1 Lung Cancer Invasion
3.1.1 Transformation of Normal Cell into Cancerous Cell
3.1.2 Tumor Heterogeneity and Cancer Stem Cells
3.1.3 Dissemination of Tumor Cell and Cell Motility
3.2 Lung Cancer Metastasis
3.2.1 Angiogenesis and Lymphangiogenesis
3.2.2 Intravasation, Circulation and Extravasation
Lung Cancer Vaccine Mechanism
4.1 Mechanism of Lung Cancer Vaccination
4.2 Rationale for Using Lung Cancer Vaccines
4.2.1 Regulatory T- Lymphocytes (Tregs)
4.2.2 Macrophages
Clinical Trials of Lung Cancer Vaccines
Global Lung Cancer Incidence Rate
6.1 U.S
6.2 Europe
6.3 Asia
6.4 Rest of the World
Global Lung Cancer Vaccine Market Overview
7.1 Current Market Scenario
7.2 Global Lung Cancer Vaccine Pipeline Overview
7.3 Global Lung Cancer Vaccine Market Future Prospects
Need for Personalized Breast Cancer Vaccines
Lung Cancer Vaccine Clinical Pipeline by Company and Phase
9.1 Preclinical
9.2 Phase-I
9.3 Phase-II
Non Small Cell Lung Cancer Vaccine Clinical Pipeline by Company and Phase
10.1 Research
10.2 Preclinical
10.3 Phase-I
10.4 Phase-I/II
10.5 Phase-II
10.6 Phase-II/III
10.7 Phase-III
Small cell lung Cancer Vaccine Clinical Pipeline by Company and Phase
11.1 Phase-II
Marketed Lung Cancer Vaccine Clinical and Patent Insight
12.1 Epidermal Growth Factor Cancer Vaccine
12.2 Mycidac-Candtrade;
12.3 Racotumomab (Vaxira)
No Development Reported and Discontinued Lung Cancer Vaccine Clinical Pipeline by Company, Indication and Phase
13.1 No Development Reported
13.2 Discontinued
13.3 Suspended
Competitive Landscape
14.1 Argos Therapeutics
14.2 Boehringer Ingelheim
14.3 Cadila Pharmaceuticals
14.4 CureVac
14.5 Eli Lily
14.6 Galaxo
14.7 ImClone Systems
14.8 Inovio Pharmaceuticals
14.9 Merck
14.10 NewLink Genetics
14.11 Northwest Biotherapeutics
14.12 Ono Pharmaceutical
14.13 Oncothyreon Incorporation
14.14 OSE Immunotherapeutics
Download Report:https://www.kuickresearch.com/report-global-lung-cancer-vaccine-market-and-pipeline-outlook-2022.php
Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.
Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lung Cancer Vaccine Market Lung Cancer Vaccine Clinical Pipeline Report 2022 here
News-ID: 618607 • Views: …
More Releases from Kuick Resarch

Targeted Alpha Therapy Market
Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights:
• Global Targeted Alpha Therapy Market Insight By Region
• Approved Targeted Alpha Therapy Dosage & Pricing Insight
• Number Of Targeted Alpha Therapy In Clinical Trials: > 20 Drugs
• Targeted Alpha Therapy Clinical Trials Insight By Company, Country, Indication & Phase
• Marketed Targeted Alpha Therapy Clinical Insight By Company, Country & Indication
• Targeted Alpha Therapy Proprietary Technology Platform Insights By…

Global Cancer Antibody Drug Conjugates Market
Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions:
• Global Cancer Antibody Drug Conjugates Market: 2020 - 2030
• Global Cancer Antibody Drug Conjugates Market Opportunity > US$ 50 Billion By 2030
• Approved Cancer Antibody Drug Conjugates: 16 Drugs
• Approved Cancer Antibody Drug Conjugates Sales Insights, Patent, Dosage and Price Analysis
• Cancer Antibody Drug Conjugates In Clinical Trials: > 500 Drugs
• Cancer Antibody Drug Conjugates Clinical…

Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…

Bispecific Antibody Drug Conjugates Development
The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity of bispecific antibodies with the powerful cytotoxic effects of drug conjugates, creating a new class of therapeutic agents that hold great promise for treating complex and resistant cancers. The process of developing these ADCs involves intricate design, engineering, and testing to ensure their safety, efficacy,…
More Releases for Cancer
Targeted Cancer Therapies Market Outlook, Innovations Driving Personalized Cance …
Overview of the Targeted Cancer Therapies Market
The targeted cancer therapies market has been rapidly evolving, driven by the urgent need for precision medicine that directly attacks cancer cells with minimal harm to healthy tissues. This market encompasses a broad range of therapeutic agents including monoclonal antibodies, small molecule inhibitors, and gene therapies designed to interfere with specific molecular targets involved in cancer progression. By the end of this forecast period,…
Global Stomach Cancer And Gastric Cancer Treatment Market Size by Application, T …
The growth of the stomach cancer and gastric cancer treatment market is primarily driven by the increasing global incidence of gastric cancer, which is one of the leading causes of cancer-related deaths worldwide. Factors such as unhealthy eating habits, smoking, and family history contribute to the rise in gastric cancer cases. Additionally, advances in treatment options, including targeted therapies, immunotherapy, and novel combination regimens, are transforming the landscape of gastric…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Cancer Photodynamic Therapy Market: A Breakthrough in Cancer Treatment
Cancer Photodynamic Therapy Market Size And Forecast by 2031
Global cancer photodynamic therapy market size was valued at USD 3.76 billion in 2023 and is projected to reach USD 5.25 billion by 2031, with a CAGR of 4.25% during the forecast period of 2024 to 2031.
Cancer Photodynamic Therapy Market research report provides a comprehensive analysis of the market. The report aims to provide insights into Cancer Photodynamic Therapy Market trends,…
Customs Kicking Cancer: A Ride to Conquer Prostate Cancer
Supporting those affected by prostate cancer by creating space for direct and honest conversations.
Image: https://www.getnews.info/uploads/581d6561676b2ffde087aef5dabfa5c5.JPG
Customs Kicking Cancer, a nonprofit organization, is making a mark among the motorcycle and car enthusiast community by raising awareness about prostate cancer, encouraging early detection, and providing free PSA testing kits.
Customs Kicking Cancer is the brainchild of Dan Lucas Jr., the son of a prostate cancer warrior. Inspired by the personal journey of his father,…